col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


6 Ergebisse       Seite 1

 [1] 
Elsevier: Biochimica et Biophysica Acta (BBA) - General Subjects
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2023―Aug―04 Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target David W. Litchfield, Laszlo Gyenis, Daniel Menyhart, Scott E. Roffey
2 [GO] 2023―Feb―09 SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses Fengling Li, Pegah Ghiabi, Taraneh Hajian, Martin Klima, Alice Shi Ming Li, Aliakbar Khalili Yazdi, et al. (+9)
3 [GO] 2022―Dez―05 Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development Aliaksandra A. Reutovich, Ayush K. Srivastava, Paolo Arosio, Fadi Bou-Abdallah
4 [GO] 2021―Jul―31 Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, pharmaceutical point of view Ali Najmeddin, Mina Bahrololoumi Shapourabadi, Mahdi Behdani, Farid Dorkoosh
5 [GO] 2021―Mrz―15 Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate Wen-Hsiang Chen, Junfei Wei, Rakhi Tyagi Kundu, Rakesh Adhikari, Zhuyun Liu, Jungsoon Lee, et al. (+12)
6 [GO] 2020―Nov―22 Can food and food supplements be deployed in the fight against the COVID 19 pandemic? Cagla Celik, Ayse Gencay, Ismail Ocsoy
 [1] 

6 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec